The Next Phase: Exploring Innovation in Clinical Trials

Technology and DCT have enormous potential. But discernment is key; we must learn from what worked and didn't, integrating technologies that enhance patient-centricity without overloading sites. Joined by Nael Abdelsamad and his extensive experience, we’ll navigate the shift towards decentralized trials to leveraging AI and machine learning, uncovering the keys to sustained innovation and patient-...

What steps can industry leaders take to foster standardization and cooperation among different technological platforms? In this episode, Rick Malone , previous president of the McCreadie Group and current Business Development Director at Inovalon , shares his strategic vision navigating the ever-evolving landscape of clinical research, where he emphasizes the importance of collaboration between ph...

Have you ever wondered how advanced technology could revolutionize clinical trials? This is disruptive innovation, using technology to seamlessly solve the clinical industry's biggest challenges. In this enlightening episode, we're joined by Dr Gordon Harris , co-founder and Chief Science Officer at Yunu , where they've found the biggest challenges and problems to solve, from being a solution for...

With an industry that is based on data and numbers, it's important to stay ahead of the game. It's what you do in the present that will redeem the past and thereby change the future. For this episode, we’re joined by Mazhar Jaffry , a physician doctor with extensive experience in the marketing sales business development, and is the founder and CEO of Revival Research Institute, LLC . Dr. Jaffry ta...

The only way to drive innovation and improve the efficiency of the sector is to create alliances and be collaborative; to be able to do more together than separately with patient-centered objectives. In this episode, we discuss the challenges and innovations that are transforming the landscape of drug development and clinical trials, and how we can grow in a market with so many players. Carlos Ora...

Innovation that makes a difference is driven by the people that it impacts the most and is focused on value propositions. In today's episode, we delve into the pivotal shift towards digital over the past seven years. Matt Smith , VP of Research Site Development at Slope , emphasizes the necessity of streamlining research processes and making the lives of those involved in research easier . Matt ex...

Our latest guest is Sandy Smith , Senior VP of Clinical Solutions and Strategic Partnerships at WCG , a company that connects sponsors, CROs, sites, and participants to deliver efficient, safe and impactful clinical research. In this conversation, Sandy shares insights into her background as an advanced practice nurse and how she landed 3 years ago at WCG where she leads Clinical Solutions and Str...

Accreditation and standardization are the keys to driving positive change in the clinical research industry, leaving a lasting legacy and making strides toward global collaboration. Today we’re joined by Jacqueline Johnson North , CEO and Co-Founder of GCSA . The Global Clinical Site Assessment Standard enables clinical research sites, CROs, and sponsors to work synergistically, while fostering a...

The success of any piece of software or solution = the quality of the solution x the buy-in and adoption of that solution. In today’s episode, our guest Dave Hine Senior Director of Sales Engineering at Greenphire , shares his unique journey from aerospace engineering to the clinical trial industry. The conversation highlights the importance of patient-centricity, explores Greenphire's innovative...

A unified system that enhances patient care, improves outcomes, and advances research to ensure the right patients receive the right therapies … That’s the goal. Our latest guest, Melisa Tucker , is a healthcare industry expert with a significant background in healthcare innovation and data utilization. She is currently serving as Head of Research Evidence Generation Program at Verily . Melisa dis...

By connecting individuals to roles and organizations that require their skills, we can accelerate medical progress, leading to longer and healthier lives. Thus, more birthdays. In today’s episode, we’re excited to be joined by Lauren Stockwell , Director of Outreach and Engagement for Clinical Research Fastrack . Lauren and I discuss the evolving landscape of talent in clinical research and the im...

The realm of clinical research holds boundless opportunities. Our latest guest, Julia Sundari , Senior Director of Clinical Design and Analytics at IQVIA , joins us with 30 intentional and passionate years in the industry, all beginning with participation in a research trial for NASA. In this episode we dive deep into innovative approaches such as risk-based monitoring, remote monitoring, and syst...

Building better protocols — As we think about DCTs, site capabilities, diversity, equity & inclusion, and going global in research, it comes down to how protocol is designed and then ultimately, how regulatory agencies are going to view and deliver on these promises. Our latest guest Douglas Reichgott , Executive Director of Clinical Research at Beth Israel Deaconess Medical Center , shares hi...

The ultimate goal in the Clinical Research space is to make trials more accessible to the broader population. Inevitably, the industry has been struggling with enrollment and recruitment. In this episode, our guest Darcy Forman , Chief Delivery Officer at Science 37 , shares insight into the implications of increasing clinical research accessibility, from increasing awareness among the general pop...

Clinical research is moving faster than ever. With developments in technology, distributed trials and accelerated research opportunities, the way we treat patients is adapting. According to Lauren Chang , VP of Strategic Growth at Clinical Research Fastrack, working in the evolving, accelerated world of clinical research takes a particular skillset — something she’s dedicated herself to helping cu...

The focus on diversity, equity and inclusion (DEI) is gaining momentum across pharma and clinical trial environments. But, often, initiatives are difficult to enact within existing industry infrastructures. To truly embrace DEI in clinical trials, clinical trials must enter community clinics — many of which are not quite ready to enter the trials space. While the challenge is no small feat, our la...

As a college student in Nashville, our guest answered a radio ad to participate in a clinical trial and was offered a part-time job filing regulatory documents and pushing papers. Now she’s a leader in the world of clinical biotechnology research and early-phase oncological development. Suzanne Kincaid , Chief Operating Officer at Aperio Clinical Outcomes , is excited to witness inspiring innovati...

Technology has streamlined systems, eased technical processes and accelerated innovation, especially in recent years. But what’s to come is perhaps more exciting. Technology and innovation is set to open the world of clinical trials to be more accessible to each and every person around the world. On this episode, we’re joined by Susan Mauermann, Start-up Specialist and Jennifer Brown , Manager of...

Whether we like it or not, technology is becoming a part of our daily lives. This is no different in the clinical research industry as well. Our guest today joins us to talk about how innovation in clinical research starts with technology. Tyler Payne is the Director of Conduct Enablement, Clinical Trial Services at CVS Health. In this episode, Tyler gives insights into the clinical research indus...

The clinical research industry is rapidly evolving, from virtual trials to precision medicine, with new trends emerging. Our guest today has over 20 years of clinical research experience and a passion for patient care and developing teams that thrive. Kimberly Jenkins is the Research Administrator at Cleveland Clinic , a multispecialty academic medical center that integrates clinical and hospital...

When you’re halfway around the world and you need to make a purchase, it’s as easy as pulling a plastic card out of your wallet and swiping. Why can’t we have the same simplicity with our healthcare data?   The answer is complex, according to Arlen Meyers, President and CEO of the Society of Physician Entrepreneurs. A medical doctor and a startup consultant, Dr. Meyers, discusses all the ways we c...

You wouldn’t take a drug if you didn’t know if it was going to help you.  It might surprise you to hear millions of people do this every day. Not because they don’t care or don’t want to know, but because they live in a system that wasn’t built for them.   This is the reality for underrepresented communities and racial and ethnic minorities who have been all-but-locked-out of the clinical trial pr...

Capping off season 2 of “The Next Phase,” this episode looks back at the insights and key learnings gleaned from conversations with industry experts as they’ve unpacked the innovations driving clinical research in a post-pandemic economy. Blake is joined by Florence Healthcare's co-founder and CEO Ryan Jones to discuss what’s happening in clinical research today and the innovations Ryan anticipate...

This episode dives into epidemiology and real-world evidence, as host Blake Adams and Paul Petraro, Global Head of Real World Evidence, Data Analytics, Value Evidence and Outcomes for Boehringer Ingelheim explore the evolution of real-world data, its use cases, and the need for trust and transparency when leveraging information across the clinical research industry.

As the world becomes increasingly digital, clinical trials using real-world evidence are armed with more data than ever before. In this episode, Blake speaks with Tracey Robertson, Global Process Lead for Boehringer Ingelheim, about how researchers can take that data and turn it into findings that support actionable outcomes and leverage technology that makes trials effective, scalable, and impact...